Kareem Zaki

Background

Kareem Zaki is a General Partner at Thrive Capital, where he has been for over a decade ¹². His family is originally from Egypt, though he has lived in the United States for most of his life ³. He is a person of Christian faith ⁴.

Zaki attended Harvard University, where he earned a Bachelor of Arts in Economics and Healthcare Policy ⁵⁶. He initially considered a career in medicine before pivoting to finance, recognizing that healthcare extended beyond clinical practice ³.

After Harvard, Zaki worked as an Investment Banking Analyst at JP Morgan, a Business Analyst at McKinsey & Company, and then spent three years as a Private Equity Investor at The Blackstone Group, where he gained exposure to healthcare assets and system-level innovation opportunities ¹³⁵.

Zaki joined Thrive Capital in 2014, where he initially focused on healthcare and financial services investments ¹⁵. He led the firm’s investments in companies including Robinhood and Ramp, and simultaneously co-founded and scaled multiple healthcare companies from within Thrive ¹². He was selected for the Forbes 30 Under 30 list in 2018 in the Venture Capital category ⁵.

Zaki is notable for blending founder and investor roles. He co-founded Cedar (healthcare payments, valued at $3.2B), Nava Benefits (healthcare brokerage), Cadence (chronic disease management), Rightway Healthcare (healthcare navigation), and Scope Security ¹²⁷⁸. Joshua Kushner, Thrive’s founder, has called Zaki “the best healthcare investor in the world” and noted that he has co-founded three healthcare businesses worth over one billion dollars ⁴.

Stated Thesis

(Self-reported: These represent what Zaki says publicly about his approach. See Inferred Thesis for analysis of actual investment behavior.)

Zaki has articulated Thrive’s investment philosophy across several podcast appearances and interviews:

• One rule – category-defining companies: Zaki has stated that Thrive’s singular investment principle is to back category-defining companies with long-term structural advantages: “We’ve really done it without any rules. We’ve been very opportunistic, and we’ve only really had one rule, and that is to be a part of category-defining companies with multi-decade tailwinds” ¹.

• Partnerships over deals: Zaki emphasizes relationship-oriented investing over transactional deal-making: “I wish that more and more people think about it as partnerships and not deals” ¹.

• Stage-agnostic, life-cycle investing: Zaki has described Thrive’s approach as covering companies from seed through public markets with one investing team, so founders work with the same partner throughout their journey. He has noted that Thrive does not feel “constrained by whether a company was private or public” ⁹.

• Building within existing systems in healthcare: Zaki has stated that meaningful healthcare disruption requires working within existing structures rather than replacing them, noting that the U.S. healthcare system suffers from a lack of competition and isolated systems ⁴.

• Small ideas attract competition: Zaki has emphasized that entrepreneurs should focus on solving large, significant problems rather than pursuing incremental ideas, a philosophy captured in the title of his Invest Like the Best podcast episode ⁴.

• Operator-investor hybrid: Zaki has described how Thrive’s company-building practice informs its investing: “We are building stuff ourselves, which really enables us to appreciate how hard it is to actually build. We are investing in early stage companies and as a result of us building those early stage companies actually want us to be their partners” ¹⁰.

Inferred Thesis

The following analysis is based on 28 verified investments and co-founded companies attributed to Kareem Zaki individually, compiled from Crunchbase, press coverage, podcast appearances, and board membership records ^12561112.

Sector Allocation (computed from 28 verified portfolio entries)

• Healthcare / Health Tech: 10 companies (36%) – Cedar, Nava Benefits, Cadence, Rightway Healthcare, Headway, Honor, Welkin, Scope Security, Trialspark, Pipo Saude
• Fintech / Financial Services: 9 companies (32%) – Robinhood, Ramp, Affirm, Lemonade, Trade Republic, Pleo, Clair, Morty, Stripe
• Enterprise / Software: 4 companies (14%) – Ramp (also fintech), Vetcove, Rize, Scope Security (also health)
• Consumer / Internet: 3 companies (11%) – Instagram, Glossier, Instacart
• AI / Technology: 2 companies (7%) – OpenAI (firm-level), GitHub

Note: Some companies span multiple categories (e.g., Ramp is both fintech and enterprise, Scope Security bridges health and enterprise). Each is counted once in its primary category. Percentages computed from 28 companies and total 100%.

Dominant Pattern: Healthcare + Fintech Specialist

Zaki’s portfolio is heavily concentrated in healthcare (36%) and fintech (32%), accounting for 68% of his verified investments – 19 of 28 companies. This makes him a clear sector specialist within Thrive’s generalist platform. His healthcare focus is reinforced by his co-founding of 5 healthcare companies (Cedar, Nava, Cadence, Rightway, Scope Security) ¹².

Stage Distribution

Zaki invests across stages consistent with Thrive’s platform approach, but with a notable emphasis on earlier-stage and incubated companies: - Co-founded / Incubated: 5 companies (18%) – Cedar, Nava, Cadence, Rightway, Scope Security - Early-stage (Seed/Series A): At least 8 companies (29%) – Headway (Series A, 2020), Morty, Clair, Honor, Welkin, Trialspark, Vetcove, Pipo Saude - Growth-stage: At least 10 companies (36%) – Ramp, Robinhood, Affirm, Trade Republic, Lemonade, Pleo, Stripe, Instacart, Glossier, Instagram - Unknown stage: 5 companies (18%)

This mix of incubation and investing is distinctive – few VCs at firms of Thrive’s scale also co-found companies within their own portfolio.

Geographic Focus

Based on verified portfolio companies, Zaki’s investments are predominantly US-based, with notable international positions including Trade Republic (Germany), Pleo (Denmark/London), and Pipo Saude (Brazil) ¹⁹. The US investments are concentrated in New York (Cedar, Nava, Headway, Ramp, Clair) and the San Francisco Bay Area (Robinhood, Stripe, Instacart).

Check Size

Signal NFX reports Zaki’s check size range as $100K to $50M with a sweet spot around $25M ¹³. This is consistent with Thrive’s broad stage coverage, with smaller checks for incubated and seed-stage companies and larger checks for growth-stage deals. Thrive has invested in Ramp four times, with increasing check sizes at each round ¹².

Co-Investor Patterns

Based on the verified portfolio, Zaki’s investments frequently co-occur with: Andreessen Horowitz (Cedar, Headway), Founders Fund (Ramp), General Catalyst (multiple Thrive portfolio companies), Khosla Ventures (Ramp), Goldman Sachs (Ramp), and Spark Capital (Headway). Within Thrive, Zaki works alongside Joshua Kushner, Miles Grimshaw, and Vince Hankes ¹¹¹²¹⁴.

Notable Gaps Between Stated and Actual Thesis

• Stated: generalist within Thrive. Actual: clear healthcare and fintech specialist. While Zaki describes Thrive as opportunistic and sector-agnostic, his personal portfolio is heavily concentrated in healthcare (36%) and fintech (32%). His consumer and AI exposure appears to come primarily from firm-level Thrive investments rather than deals he personally led.
• Stated: investor. Actual: also a prolific company-builder. Zaki’s co-founding of 5 companies (Cedar, Nava, Cadence, Rightway, Scope Security) makes him as much an operator as an investor. This is a differentiating factor for founders evaluating him – he brings direct company-building experience, not just capital.
• Healthcare focus is significantly deeper than Thrive’s overall portfolio suggests. Thrive’s firm profile shows healthcare at roughly 8% of the portfolio. Zaki’s personal allocation to healthcare is 36% – more than 4x the firm’s average, confirming Kushner’s description of him as Thrive’s healthcare specialist.

Portfolio

The following table includes 28 verified investments and co-founded companies attributed to Kareem Zaki individually. Thrive Capital as a firm has invested in approximately 199 companies; this table represents only investments where Zaki is identified as the lead partner, board member, or co-founder.

Note: This table represents investments where Zaki is specifically identified as lead, board member, or co-founder. Investment years use “~YYYY” where specific dates are approximate. Many additional Thrive Capital investments involve Zaki but cannot be individually attributed from public sources.

In Their Own Words

On Thrive’s one investing rule:

“We’ve really done it without any rules. We’ve been very opportunistic, and we’ve only really had one rule, and that is to be a part of category-defining companies with multi-decade tailwinds.” – Kareem Zaki, The Twenty Minute VC, November 2021 ¹

On partnerships vs. deals:

“I wish that more and more people think about it as partnerships and not deals.” – Kareem Zaki, The Twenty Minute VC, November 2021 ¹

On the operator-investor hybrid model:

“We are building stuff ourselves, which really enables us to appreciate how hard it is to actually build. We are investing in early stage companies and as a result of us building those early stage companies actually want us to be their partners.” – Kareem Zaki, Bloomberg, October 2022 ¹⁰

On stage-agnostic investing:

“We just wanted to be in a position that we didn’t feel constrained by whether a company was private or public.” – Kareem Zaki, A Letter a Day, 2023 ⁹

On Ramp:

“Ramp has a powerful combination of a tenacious team that is fast-executing, and a massive market with strong structural tailwinds.” – Kareem Zaki, Ramp Series D press release, 2023 ¹²

“The companies that will matter most are those turning these advances into tangible value and economic gains. Ramp has been quietly doing this since day one – taking processes that used to take hours and reducing them to seconds, all with the goal of helping businesses run more efficiently and profitably.” – Kareem Zaki, Ramp $13B secondary press release, 2025 ¹⁶

On Ramp’s product focus:

“The corporate card is important, but more so is the integration, full-time sync and the financial products like loans and payments. There is value to be created by unlocking new behaviors.” – Kareem Zaki, Crunchbase News, 2021 ¹¹

On Cedar and healthcare billing:

“The consumer experience in healthcare lags behind nearly every other industry – this is painfully obvious when you look at the current patient billing process.” – Kareem Zaki, Cedar launch press release, 2017 ⁷

On healthcare optimism:

“I’m very optimistic for the future of healthcare because I’ve seen up-close a lot of amazing companies and products being built today.” – Kareem Zaki, Nava Benefits, 2021 ³

What Founders Say

No independently sourced founder testimonials specifically about Kareem Zaki were found in this research pass. The HLTH 2024 conference featured a joint panel titled “Leveraging the Founder/Investor Relationship to Build a New Mental Healthcare System” with Andrew Adams (CEO, Headway) and Kareem Zaki, indicating a close founder-investor relationship, but no public quotes from Adams about Zaki were located ¹⁵.

Joshua Kushner, Thrive’s founder, has described Zaki as “the best healthcare investor in the world” and noted that he has co-founded three healthcare businesses worth over one billion dollars ⁴. While Kushner is a colleague rather than a portfolio founder, this speaks to Zaki’s internal reputation.

Zaki’s dual role as co-founder of Cedar, Nava, Cadence, Rightway, and Scope Security means that some of his most important “portfolio” relationships are ones where he is himself a founder, making traditional founder-investor testimonials less applicable to those companies.

Sources